Humira Biosimilars Enter the Marketplace – Update on Navitus’ Review
The market entry of biosimilars to Humira® (adalimumab) is long-awaited. These products have the potential to improve affordability in the near- and...
Five Forecasts and Takeaways for Plan Sponsors in 2023
As we enter 2023, David Fields is sharing his top forecasts and takeaways for plan sponsors and the PBM industry.
Understanding the Inflation Reduction Act of 2022
Navitus’ Vice President of Government Relations, Robyn Crosson, shares her insight into the Inflation Reduction Act and how it will impact our...
What You Need to Know About Fraud, Waste and Abuse in The Age of COVID-19
Carrie Aiken, Navitus’ Vice President of Corporate Compliance and Chief Compliance Officer, shares her perspective on how PBMs can help plan sponsors...
Building Specialty Pharmacy Success
Sharon Faust, PharmD, Vice President of Specialty Pharmacy for Lumicera shares a few key initiatives that will continue to create an impact for...
Know Your Options for At-Home COVID-19 Test Kits
As a member, plan sponsor or consultant, do you understand what the new federal guidance on free at-home COVID-19 tests means to you? As part of...
COVID-19 Vaccine Update: Booster Shots
As the country strives to get ahead of the Coronavirus by getting as many vaccinated as possible, booster shots may help extend protection. Get the...
How PBMs Can Help Plan Sponsors Combat Fraud, Waste and Abuse
Carrie Aiken, Navitus’ Vice President of Corporate Compliance and Chief Compliance Officer, shares her perspective on how PBMs can help plan sponsors...
PBM Admin Fees: There's no such things as a free lunch
Learning the difference between traditional and pass-through PBM admin fees is one way to see your true pharmacy costs.
Recap: Navitus Featured in Two News Articles
Business Insider and the Wisconsin State Journal recently featured Navitus and how its alternative PBM business model is gaining attention among...
